| Year |
Citation |
Score |
| 2024 |
Mejias Rivera L, Shore EM, Mourkioti F. Cellular and Molecular Mechanisms of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva. Biomedicines. 12. PMID 38672135 DOI: 10.3390/biomedicines12040779 |
0.385 |
|
| 2023 |
Sangadala S, Shore EM, Xu M, Bergwitz C, Lozano-Calderon SA, Lin AE, Boden SD, Kaplan FS. Multifocal heterotopic ossification in a man with germline variants of LIM Mineralization Protein-1 (LMP-1). American Journal of Medical Genetics. Part A. PMID 37218523 DOI: 10.1002/ajmg.a.63304 |
0.343 |
|
| 2022 |
Yang YS, Kim JM, Xie J, Chaugule S, Lin C, Ma H, Hsiao E, Hong J, Chun H, Shore EM, Kaplan FS, Gao G, Shim JH. Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery. Nature Communications. 13: 6175. PMID 36258013 DOI: 10.1038/s41467-022-33956-9 |
0.339 |
|
| 2022 |
Wentworth KL, Lalonde RL, Groppe JC, Brewer N, Moody T, Hansberry S, Taylor K, Shore EM, Kaplan FS, Pignolo RJ, Yelick PC, Hsiao EC. Functional testing of BMP pathway variants identified on whole exome sequencing in a patient with delayed-onset fibrodysplasia ossificans progressiva (FOP) using ACVR1 -specific human cellular and zebrafish models. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 36153796 DOI: 10.1002/jbmr.4711 |
0.42 |
|
| 2021 |
Lau YK, Peck SH, Arginteanu T, Wu M, Lin M, Shore EM, Klein PS, Casal ML, Smith LJ. Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs. Bone. 116237. PMID 34695616 DOI: 10.1016/j.bone.2021.116237 |
0.379 |
|
| 2021 |
Towler OW, Shore EM. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP). Developmental Dynamics : An Official Publication of the American Association of Anatomists. PMID 34133058 DOI: 10.1002/dvdy.387 |
0.483 |
|
| 2020 |
Towler OW, Peck SH, Kaplan FS, Shore EM. Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP). Developmental Biology. PMID 33217406 DOI: 10.1016/j.ydbio.2020.11.004 |
0.407 |
|
| 2020 |
Allen RS, Tajer B, Shore EM, Mullins MC. Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish. Elife. 9. PMID 32897189 DOI: 10.7554/Elife.53761 |
0.446 |
|
| 2020 |
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Garcia Ramirez A, Germain-Lee EL, Groussin L, ... ... Shore EM, et al. Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients. Hormone Research in Paediatrics. 1-15. PMID 32756064 DOI: 10.1159/000508985 |
0.32 |
|
| 2020 |
Kaplan FS, Al Mukaddam M, Stanley A, Towler OW, Shore EM. Fibrodysplasia Ossificans Progressiva (FOP): A Disorder of Osteochondrogenesis. Bone. 115539. PMID 32730934 DOI: 10.1016/J.Bone.2020.115539 |
0.522 |
|
| 2020 |
Allen RS, Tajer B, Shore EM, Mullins MC. Author response: Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish Elife. DOI: 10.7554/Elife.53761.Sa2 |
0.36 |
|
| 2019 |
Towler OW, Shore EM, Kaplan FS. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. Bone. 115116. PMID 31655222 DOI: 10.1016/J.Bone.2019.115116 |
0.514 |
|
| 2019 |
Peck SH, Tobias JW, Shore EM, Malhotra NR, Haskins ME, Casal ML, Smith LJ. Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII. Bone. 115042. PMID 31442675 DOI: 10.1016/J.Bone.2019.115042 |
0.445 |
|
| 2019 |
Ware AD, Brewer N, Meyers C, Morris C, McCarthy E, Shore EM, James AW. Differential Vascularity in Genetic and Nonhereditary Heterotopic Ossification. International Journal of Surgical Pathology. 1066896919857135. PMID 31250694 DOI: 10.1177/1066896919857135 |
0.335 |
|
| 2019 |
Stanley A, Heo SJ, Mauck RL, Mourkioti F, Shore EM. Elevated BMP and mechanical signaling through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31107558 DOI: 10.1002/Jbmr.3760 |
0.542 |
|
| 2019 |
Gucev Z, Tasic V, Plaseska-Karanfilska D, Dimishkovska M, Laban N, Bozinovski Z, Kostovski M, Saveski A, Polenakovic M, Towler OW, Shore EM, Kaplan FS. Severe digital malformations in a rare variant of fibrodysplasia ossificans progressiva. American Journal of Medical Genetics. Part A. PMID 31012264 DOI: 10.1002/Ajmg.A.61153 |
0.315 |
|
| 2019 |
Casal ML, Engiles JB, Zakošek Pipan M, Berkowitz A, Porat-Mosenco Y, Mai W, Wurzburg K, Xu MQ, Allen R, ODonnell PA, Henthorn PS, Thompson K, Shore EM. Identification of the Identical Human Mutation in ACVR1 in 2 Cats With Fibrodysplasia Ossificans Progressiva. Veterinary Pathology. 300985819835585. PMID 31007133 DOI: 10.1177/0300985819835585 |
0.39 |
|
| 2019 |
Chakkalakal SA, Shore EM. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva. Methods in Molecular Biology (Clifton, N.J.). 1891: 247-255. PMID 30414138 DOI: 10.1007/978-1-4939-8904-1_18 |
0.456 |
|
| 2019 |
Rauner M, Seefried L, Shore E. Genetics and future therapy prospects of fibrodysplasia ossificans progressiva Medizinische Genetik. 31: 391-396. DOI: 10.1007/S11825-019-00279-Y |
0.502 |
|
| 2018 |
Haupt J, Stanley A, McLeod CM, Cosgrove BD, Culbert AL, Wang L, Mourkioti F, Mauck RL, Shore EM. ACVR1 FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification. Molecular Biology of the Cell. mbcE18050311. PMID 30379592 DOI: 10.1091/Mbc.E18-05-0311 |
0.509 |
|
| 2018 |
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, ... ... Shore EM, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nature Reviews. Endocrinology. PMID 29959430 DOI: 10.1038/S41574-018-0042-0 |
0.35 |
|
| 2018 |
Amalfitano M, Fyfe B, Thomas SV, Egan KP, Xu M, Smith AG, Kaplan FS, Shore EM, Pignolo RJ. A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings. Bone. PMID 29320714 DOI: 10.1016/J.Bone.2018.01.006 |
0.357 |
|
| 2018 |
Mucha BE, Hashiguchi M, Zinski J, Shore EM, Mullins MC. Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish. Bone. PMID 29307777 DOI: 10.1016/J.Bone.2018.01.002 |
0.433 |
|
| 2018 |
Kaplan FS, Pignolo RJ, Mukaddam MA, Shore EM. Genetic disorders of heterotopic ossification: Fibrodysplasia ossificans progressiva and progressive osseous heteroplasia Primer On the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 865-870. DOI: 10.1002/9781119266594.Ch112 |
0.332 |
|
| 2017 |
Ramaswamy G, Fong J, Brewer N, Kim H, Zhang D, Choi Y, Kaplan FS, Shore EM. Ablation of Gsα signaling in osteoclast progenitor cells adversely affects skeletal bone maintenance. Bone. PMID 29183785 DOI: 10.1016/J.Bone.2017.11.019 |
0.476 |
|
| 2017 |
Wang H, Shore EM, Pignolo RJ, Kaplan FS. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP). Bone. PMID 29170109 DOI: 10.1016/J.Bone.2017.11.014 |
0.556 |
|
| 2017 |
Haupt J, Xu M, Shore EM. Variable signaling activity by FOP ACVR1 mutations. Bone. PMID 29097342 DOI: 10.1016/J.Bone.2017.10.027 |
0.407 |
|
| 2017 |
Convente MR, Chakkalakal SA, Yang E, Caron RJ, Zhang D, Kambayashi T, Kaplan FS, Shore EM. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1(R206H) Mouse Model of Fibrodysplasia Ossificans Progressiva. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28986986 DOI: 10.1002/Jbmr.3304 |
0.392 |
|
| 2017 |
Loro E, Ramaswamy G, Chandra A, Tseng WJ, Mishra MK, Shore EM, Khurana TS. IL15RA is required for osteoblast function and bone mineralization. Bone. PMID 28602725 DOI: 10.1016/J.Bone.2017.06.003 |
0.461 |
|
| 2017 |
Towler OW, Shore EM, Xu M, Bamford A, Anderson I, Pignolo RJ, Kaplan FS. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call. European Journal of Medical Genetics. PMID 28473268 DOI: 10.1016/J.Ejmg.2017.04.013 |
0.475 |
|
| 2017 |
Ramaswamy G, Kim H, Zhang D, Lounev V, Wu JY, Choi Y, Kaplan FS, Pignolo RJ, Shore EM. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways. Scientific Reports. 7: 45140. PMID 28338087 DOI: 10.1038/Srep45140 |
0.488 |
|
| 2017 |
MacFarlane EG, Haupt J, Dietz HC, Shore EM. TGF-β Family Signaling in Connective Tissue and Skeletal Diseases. Cold Spring Harbor Perspectives in Biology. PMID 28246187 DOI: 10.1101/Cshperspect.A022269 |
0.365 |
|
| 2016 |
Rajapakse CS, Lindborg C, Wang H, Newman BT, Kobe EA, Chang G, Shore EM, Kaplan FS, Pignolo RJ. Analog Method for Radiographic Assessment of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva. Academic Radiology. PMID 27989444 DOI: 10.1016/J.Acra.2016.10.010 |
0.342 |
|
| 2016 |
Pang J, Zuo Y, Chen Y, Song L, Zhu Q, Yu J, Shan C, Cai Z, Hao J, Kaplan FS, Shore EM, Zhang K. ACVR1-Fc Suppresses BMP Signaling and Chondro-osseous Differentiation in an in vitro Model of Fibrodysplasia Ossificans Progressiva. Bone. PMID 27492611 DOI: 10.1016/J.Bone.2016.07.023 |
0.499 |
|
| 2016 |
Wang H, Lindborg C, Lounev V, Kim JH, McCarrick-Walmsley R, Xu M, Mangiavini L, Groppe JC, Shore EM, Schipani E, Kaplan FS, Pignolo RJ. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 27027798 DOI: 10.1002/Jbmr.2848 |
0.416 |
|
| 2016 |
Chakkalakal SA, Uchibe K, Convente MR, Zhang D, Economides AN, Kaplan FS, Pacifici M, Iwamoto M, Shore EM. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice with the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 26896819 DOI: 10.1002/Jbmr.2820 |
0.474 |
|
| 2016 |
Pacifici M, Shore EM. Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders. Cytokine & Growth Factor Reviews. 27: 93-104. PMID 26776312 DOI: 10.1016/J.Cytogfr.2015.12.007 |
0.485 |
|
| 2016 |
Kaplan FS, Pignolo RJ, Shore EM. Granting immunity to FOP and catching heterotopic ossification in the Act. Seminars in Cell & Developmental Biology. 49: 30-6. PMID 26706149 DOI: 10.1016/J.Semcdb.2015.12.013 |
0.505 |
|
| 2016 |
Han H, Baubet V, Boucher K, Pignolo R, Kaplan F, Shore E, Storm P, Dahmane N, Resnick A. HG-59ACVR1-MUTANT DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGs) ACQUIRE ABERRANT ACTIVIN-MEDIATED BMP PATHWAY ACTIVATION Neuro-Oncology. 18: iii61.2-iii61. DOI: 10.1093/Neuonc/Now073.55 |
0.319 |
|
| 2015 |
Peck SH, O'Donnell PJ, Kang JL, Malhotra NR, Dodge GR, Pacifici M, Shore EM, Haskins ME, Smith LJ. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs. Molecular Genetics and Metabolism. PMID 26422116 DOI: 10.1016/J.Ymgme.2015.09.008 |
0.445 |
|
| 2015 |
Kaplan FS, Kobori JA, Orellana C, Calvo I, Rosello M, Martinez F, Lopez B, Xu M, Pignolo RJ, Shore EM, Groppe JC. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients. American Journal of Medical Genetics. Part A. PMID 26097044 DOI: 10.1002/Ajmg.A.37205 |
0.322 |
|
| 2015 |
Convente MR, Wang H, Pignolo RJ, Kaplan FS, Shore EM. The immunological contribution to heterotopic ossification disorders. Current Osteoporosis Reports. 13: 116-24. PMID 25687936 DOI: 10.1007/S11914-015-0258-Z |
0.458 |
|
| 2015 |
Pignolo RJ, Ramaswamy G, Fong JT, Shore EM, Kaplan FS. Progressive osseous heteroplasia: diagnosis, treatment, and prognosis. The Application of Clinical Genetics. 8: 37-48. PMID 25674011 DOI: 10.2147/Tacg.S51064 |
0.37 |
|
| 2015 |
Shulman R, Ellis J, Shore E, Kaplan FS, Badell M. Maternal Genetic Skeletal Disorders: Lessons Learned From Cases of Maternal Osteogenesis Imperfecta and Fibrodysplasia Ossificans Progressiva Journal of Clinical Gynecology and Obstetrics. 4: 184-187. DOI: 10.14740/Jcgo.V4I1.306 |
0.327 |
|
| 2015 |
Peck SH, O'Donnell PJ, Shore EM, Pacifici M, Haskins ME, Malhotra NR, Smith LJ. Failed vertebral bone formation in mucopolysaccharidosis VII dogs is associated with impaired chondrocyte hypertrophic differentiation Molecular Genetics and Metabolism. 114: S91-S92. DOI: 10.1016/J.Ymgme.2014.12.203 |
0.413 |
|
| 2014 |
Duncan E, Brown M, Shore EM. The revolution in human monogenic disease mapping. Genes. 5: 792-803. PMID 25198531 DOI: 10.3390/Genes5030792 |
0.328 |
|
| 2014 |
Chiaro JA, O'Donnell P, Shore EM, Malhotra NR, Ponder KP, Haskins ME, Smith LJ. Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 2610-7. PMID 24898323 DOI: 10.1016/J.Ymgme.2013.12.244 |
0.331 |
|
| 2014 |
Haupt J, Deichsel A, Stange K, Ast C, Bocciardi R, Ravazzolo R, Di Rocco M, Ferrari P, Landi A, Kaplan FS, Shore EM, Reissner C, Seemann P. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant Human Molecular Genetics. 23: 5364-5377. PMID 24852373 DOI: 10.1093/Hmg/Ddu255 |
0.317 |
|
| 2014 |
Culbert AL, Chakkalakal SA, Theosmy EG, Brennan TA, Kaplan FS, Shore EM. Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification Stem Cells. 32: 1289-1300. PMID 24449086 DOI: 10.1002/Stem.1633 |
0.508 |
|
| 2013 |
Kaplan FS, Pignolo RJ, Shore EM. From mysteries to medicines: drug development for fibrodysplasia ossificans progressive. Expert Opinion On Orphan Drugs. 1: 637-649. PMID 24800180 DOI: 10.1517/21678707.2013.825208 |
0.414 |
|
| 2013 |
Regard JB, Malhotra D, Gvozdenovic-Jeremic J, Josey M, Chen M, Weinstein LS, Lu J, Shore EM, Kaplan FS, Yang Y. Activation of hedgehog signaling by loss of GNAS causes heterotopic ossification Nature Medicine. 19: 1505-1512. PMID 24076664 DOI: 10.1038/Nm.3314 |
0.552 |
|
| 2013 |
Zhang W, Zhang K, Song L, Pang J, Ma H, Shore EM, Kaplan FS, Wang P. The phenotype and genotype of fibrodysplasia ossificans progressiva in China: A report of 72 cases Bone. 57: 386-391. PMID 24051199 DOI: 10.1016/J.Bone.2013.09.002 |
0.346 |
|
| 2013 |
Cairns DM, Pignolo RJ, Uchimura T, Brennan TA, Lindborg CM, Xu M, Kaplan FS, Shore EM, Zeng L. Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia Journal of Clinical Investigation. 123: 3624-3633. PMID 23863715 DOI: 10.1172/Jci69746 |
0.397 |
|
| 2013 |
Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatric Endocrinology Reviews : Per. 10: 437-448. PMID 23858627 |
0.396 |
|
| 2013 |
Chiaro JA, Baron MD, Del Alcazar CM, O'Donnell P, Shore EM, Elliott DM, Ponder KP, Haskins ME, Smith LJ. Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs. Bone. 55: 78-83. PMID 23563357 DOI: 10.1016/J.Bone.2013.03.014 |
0.395 |
|
| 2013 |
Shore EM. Fibrodysplasia ossificans progressiva (FOP): A disorder of extraskeletal endochondral ossification Seminars in Arthritis and Rheumatism. 42: 546. DOI: 10.1016/J.Semarthrit.2012.12.010 |
0.565 |
|
| 2012 |
Muglu JA, Garg A, Pandiarajan T, Shore EM, Kaplan FS, Uchil D, Dickson MJ. Pregnancy in fibrodysplasia ossificans progressiva. Obstetric Medicine. 5: 35-8. PMID 27579132 DOI: 10.1258/Om.2011.110042 |
0.34 |
|
| 2012 |
La Sala LF, Pozzi LM, McAloose D, Kaplan FS, Shore EM, Kompanje EJ, Sidor IF, Musmeci L, Uhart MM. Severe soft tissue ossification in a southern right whale Eubalaena australis. Diseases of Aquatic Organisms. 102: 149-56. PMID 23269389 DOI: 10.3354/Dao02538 |
0.347 |
|
| 2012 |
Kaplan FS, Chakkalakal SA, Shore EM. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Disease Models & Mechanisms. 5: 756-62. PMID 23115204 DOI: 10.1242/Dmm.010280 |
0.516 |
|
| 2012 |
Zhang S, Kaplan FS, Shore EM. Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 44: 724-31. PMID 22903279 DOI: 10.1055/S-0032-1321845 |
0.49 |
|
| 2012 |
Kan L, Kitterman JA, Procissi D, Chakkalakal S, Peng CY, McGuire TL, Goldsby RE, Pignolo RJ, Shore EM, Kaplan FS, Kessler JA. CNS demyelination in fibrodysplasia ossificans progressiva. Journal of Neurology. 259: 2644-55. PMID 22736080 DOI: 10.1007/S00415-012-6563-X |
0.446 |
|
| 2012 |
Hammond P, Suttie M, Hennekam RC, Allanson J, Shore EM, Kaplan FS. The face signature of fibrodysplasia ossificans progressiva. American Journal of Medical Genetics. Part A. 158: 1368-80. PMID 22581580 DOI: 10.1002/Ajmg.A.35346 |
0.366 |
|
| 2012 |
Zimmer J, Doelken SC, Horn D, Groppe JC, Shore EM, Kaplan FS, Seemann P. Functional analysis of alleged NOGGIN mutation G92E disproves its pathogenic relevance. Plos One. 7: e35062. PMID 22529972 DOI: 10.1371/Journal.Pone.0035062 |
0.507 |
|
| 2012 |
Liu JJ, Russell E, Zhang D, Kaplan FS, Pignolo RJ, Shore EM. Paternally inherited gsα mutation impairs adipogenesis and potentiates a lean phenotype in vivo. Stem Cells (Dayton, Ohio). 30: 1477-85. PMID 22511293 DOI: 10.1002/Stem.1109 |
0.481 |
|
| 2012 |
Chakkalakal SA, Zhang D, Culbert AL, Convente MR, Caron RJ, Wright AC, Maidment AD, Kaplan FS, Shore EM. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 1746-56. PMID 22508565 DOI: 10.1002/Jbmr.1637 |
0.549 |
|
| 2012 |
Shore EM. Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another? Wiley Interdisciplinary Reviews. Developmental Biology. 1: 153-65. PMID 22408652 DOI: 10.1002/Wdev.9 |
0.522 |
|
| 2012 |
Kaplan J, Kaplan FS, Shore EM. Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting. Gene Therapy. 19: 786-90. PMID 22011642 DOI: 10.1038/Gt.2011.152 |
0.538 |
|
| 2012 |
Shore EM, Gannon FH, Kaplan FS. Fibrodysplasia ossificans progressiva why do some people have two skeletons? Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 3: 84-9. PMID 19078161 DOI: 10.1097/00124743-199704001-00019 |
0.521 |
|
| 2011 |
Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet Journal of Rare Diseases. 6: 80. PMID 22133093 DOI: 10.1186/1750-1172-6-80 |
0.462 |
|
| 2011 |
Kaplan FS, Lounev VY, Wang H, Pignolo RJ, Shore EM. Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis. Annals of the New York Academy of Sciences. 1237: 5-10. PMID 22082359 DOI: 10.1111/J.1749-6632.2011.06195.X |
0.459 |
|
| 2011 |
Pignolo RJ, Xu M, Russell E, Richardson A, Kaplan J, Billings PC, Kaplan FS, Shore EM. Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2647-55. PMID 21812029 DOI: 10.1002/Jbmr.481 |
0.416 |
|
| 2011 |
Kan L, Lounev VY, Pignolo RJ, Duan L, Liu Y, Stock SR, McGuire TL, Lu B, Gerard NP, Shore EM, Kaplan FS, Kessler JA. Substance P signaling mediates BMP-dependent heterotopic ossification. Journal of Cellular Biochemistry. 112: 2759-72. PMID 21748788 DOI: 10.1002/Jcb.23259 |
0.414 |
|
| 2011 |
Groppe JC, Wu J, Shore EM, Kaplan FS. In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells, Tissues, Organs. 194: 291-5. PMID 21525719 DOI: 10.1159/000324230 |
0.376 |
|
| 2011 |
Shore EM. Osteoinductive signals and heterotopic ossification. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 1163-5. PMID 21523827 DOI: 10.1002/Jbmr.404 |
0.397 |
|
| 2011 |
Shore EM, Kaplan FS. Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva. Current Osteoporosis Reports. 9: 83-8. PMID 21340697 DOI: 10.1007/S11914-011-0046-3 |
0.579 |
|
| 2010 |
Pignolo RJ, Shore EM. Circulating osteogenic precursor cells. Critical Reviews in Eukaryotic Gene Expression. 20: 171-80. PMID 21133846 DOI: 10.1615/Critreveukargeneexpr.V20.I2.70 |
0.453 |
|
| 2010 |
Kaplan FS, Seemann P, Haupt J, Xu M, Lounev VY, Mullins M, Shore EM. Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva. Methods in Enzymology. 484: 357-73. PMID 21036241 DOI: 10.1016/B978-0-12-381298-8.00018-6 |
0.532 |
|
| 2010 |
Kaplan FS, Pignolo RJ, Shore EM. Viewing FOP through rosi-colored glasses. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 2295-6. PMID 20717980 DOI: 10.1002/Jbmr.214 |
0.413 |
|
| 2010 |
Shore EM, Kaplan FS. Inherited human diseases of heterotopic bone formation. Nature Reviews. Rheumatology. 6: 518-27. PMID 20703219 DOI: 10.1038/Nrrheum.2010.122 |
0.542 |
|
| 2010 |
Kartal-Kaess M, Shore EM, Xu M, Schwering L, Uhl M, Korinthenberg R, Niemeyer C, Kaplan FS, Lauten M. Fibrodysplasia ossificans progressiva (FOP): watch the great toes! European Journal of Pediatrics. 169: 1417-21. PMID 20577760 DOI: 10.1007/S00431-010-1232-5 |
0.403 |
|
| 2009 |
Kaplan FS, Pignolo RJ, Shore EM. The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine & Growth Factor Reviews. 20: 399-407. PMID 19896889 DOI: 10.1016/J.Cytogfr.2009.10.006 |
0.491 |
|
| 2009 |
Shen Q, Little SC, Xu M, Haupt J, Ast C, Katagiri T, Mundlos S, Seemann P, Kaplan FS, Mullins MC, Shore EM. The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. The Journal of Clinical Investigation. 119: 3462-72. PMID 19855136 DOI: 10.1172/Jci37412 |
0.499 |
|
| 2009 |
Suda RK, Billings PC, Egan KP, Kim JH, McCarrick-Walmsley R, Glaser DL, Porter DL, Shore EM, Pignolo RJ. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells (Dayton, Ohio). 27: 2209-19. PMID 19522009 DOI: 10.1002/Stem.150 |
0.428 |
|
| 2009 |
Moore RE, Dormans JP, Drummond DS, Shore EM, Kaplan FS, Auerbach JD. Chin-on-chest deformity in patients with fibrodysplasia ossificans progressiva: A case series Journal of Bone and Joint Surgery - Series A. 91: 1497-1502. PMID 19487531 DOI: 10.2106/Jbjs.H.00554 |
0.417 |
|
| 2009 |
Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, Glaser DL, Goldhamer DJ, Kaplan FS. Identification of progenitor cells that contribute to heterotopic skeletogenesis. The Journal of Bone and Joint Surgery. American Volume. 91: 652-63. PMID 19255227 DOI: 10.2106/Jbjs.H.01177 |
0.426 |
|
| 2009 |
Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, Hoover-Fong J, Köster B, Pauli RM, Reardon W, Zaidi SA, ... ... Shore EM, et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Human Mutation. 30: 379-90. PMID 19085907 DOI: 10.1002/Humu.20868 |
0.488 |
|
| 2009 |
Fukuda T, Kohda M, Kanomata K, Nojima J, Nakamura A, Kamizono J, Noguchi Y, Iwakiri K, Kondo T, Kurose J, Endo K, Awakura T, Fukushi J, Nakashima Y, Chiyonobu T, ... ... Shore EM, et al. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. The Journal of Biological Chemistry. 284: 7149-56. PMID 18684712 DOI: 10.1074/Jbc.M801681200 |
0.545 |
|
| 2008 |
Kaplan FS, Groppe J, Shore EM. When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discovery Today. Therapeutic Strategies. 5: 255-262. PMID 23599718 DOI: 10.1016/J.Ddstr.2008.11.004 |
0.535 |
|
| 2008 |
Kaplan FS, Shen Q, Lounev V, Seemann P, Groppe J, Katagiri T, Pignolo RJ, Shore EM. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). Journal of Bone and Mineral Metabolism. 26: 521-30. PMID 18979151 DOI: 10.1007/S00774-008-0879-8 |
0.516 |
|
| 2008 |
Huang AH, Motlekar NA, Stein A, Diamond SL, Shore EM, Mauck RL. High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Annals of Biomedical Engineering. 36: 1909-21. PMID 18791827 DOI: 10.1007/S10439-008-9562-4 |
0.324 |
|
| 2008 |
Shore EM, Kaplan FS. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone. 43: 427-33. PMID 18590993 DOI: 10.1016/J.Bone.2008.05.013 |
0.466 |
|
| 2008 |
Adegbite NS, Xu M, Kaplan FS, Shore EM, Pignolo RJ. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. American Journal of Medical Genetics. Part A. 1788-96. PMID 18553568 DOI: 10.1002/Ajmg.A.32346 |
0.373 |
|
| 2008 |
Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J, Sillence D, Zackai E, Ravitsky V, Zasloff M, Ganguly A, Shore EM. Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics. 121: e1295-300. PMID 18450872 DOI: 10.1542/Peds.2007-1980 |
0.319 |
|
| 2008 |
Zaghloul KA, Heuer GG, Guttenberg MD, Shore EM, Kaplan FS, Storm PB. Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva. Journal of Neurosurgery. Pediatrics. 1: 91-4. PMID 18352811 DOI: 10.3171/Ped-08/01/091 |
0.417 |
|
| 2008 |
Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, Groppe J, Shore EM. Fibrodysplasia ossificans progressiva. Best Practice & Research. Clinical Rheumatology. 22: 191-205. PMID 18328989 DOI: 10.1016/J.Berh.2007.11.007 |
0.505 |
|
| 2008 |
Deirmengian GK, Hebela NM, O'Connell M, Glaser DL, Shore EM, Kaplan FS. Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva. The Journal of Bone and Joint Surgery. American Volume. 90: 366-74. PMID 18245597 DOI: 10.2106/Jbjs.G.00774 |
0.497 |
|
| 2008 |
Billings PC, Fiori JL, Bentwood JL, O'Connell MP, Jiao X, Nussbaum B, Caron RJ, Shore EM, Kaplan FS. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP) Journal of Bone and Mineral Research. 23: 305-313. PMID 17967130 DOI: 10.1359/Jbmr.071030 |
0.796 |
|
| 2007 |
Kaplan FS, Groppe J, Pignolo RJ, Shore EM. Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Annals of the New York Academy of Sciences. 1116: 113-33. PMID 17872396 DOI: 10.1196/Annals.1402.039 |
0.523 |
|
| 2007 |
Groppe JC, Shore EM, Kaplan FS. Functional modeling of the ACVR1 (R206H) mutation in FOP. Clinical Orthopaedics and Related Research. 462: 87-92. PMID 17572636 DOI: 10.1097/Blo.0B013E318126C049 |
0.362 |
|
| 2007 |
Yeon HB, Kaplan FS, Shore EM, Rosenberg AE, Jupiter JB. Focal fibronodular heterotopic ossification. A case report. The Journal of Bone and Joint Surgery. American Volume. 89: 1329-36. PMID 17545438 DOI: 10.2106/Jbjs.E.01386 |
0.321 |
|
| 2007 |
O'Connell MP, Billings PC, Fiori JL, Deirmengian G, Roach HI, Shore EM, Kaplan FS. HSPG modulation of BMP signaling in fibrodysplasia ossificans progressiva cells. Journal of Cellular Biochemistry. 102: 1493-503. PMID 17516498 DOI: 10.1002/Jcb.21370 |
0.781 |
|
| 2007 |
Kaplan FS, Glaser DL, Pignolo RJ, Shore EM. A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opinion On Biological Therapy. 7: 705-12. PMID 17477807 DOI: 10.1517/14712598.7.5.705 |
0.516 |
|
| 2007 |
Feldman GJ, Billings PC, Patel RV, Caron RJ, Guenther C, Kingsley DM, Kaplan FS, Shore EM. Over-expression of BMP4 and BMP5 in a child with axial skeletal malformations and heterotopic ossification: a new syndrome. American Journal of Medical Genetics. Part A. 143: 699-706. PMID 17345627 DOI: 10.1002/Ajmg.A.31649 |
0.491 |
|
| 2007 |
Gelfand IM, Hub RS, Shore EM, Kaplan FS, Dimeglio LA. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report. Bone. 40: 1425-8. PMID 17321228 DOI: 10.1016/J.Bone.2006.12.058 |
0.354 |
|
| 2007 |
Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG. Hematopoietic stem-cell contribution to ectopic skeletogenesis. The Journal of Bone and Joint Surgery. American Volume. 89: 347-57. PMID 17272450 DOI: 10.2106/Jbjs.F.00472 |
0.493 |
|
| 2007 |
Jiao X, Billings PC, O'Connell MP, Kaplan FS, Shore EM, Glaser DL. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. The Journal of Biological Chemistry. 282: 1080-6. PMID 17020882 DOI: 10.1074/Jbc.M513414200 |
0.458 |
|
| 2006 |
Kaplan FS, Fiori J, DE LA Peña LS, Ahn J, Billings PC, Shore EM. Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva. Annals of the New York Academy of Sciences. 1068: 54-65. PMID 16831905 DOI: 10.1196/Annals.1346.008 |
0.777 |
|
| 2006 |
Fiori JL, Billings PC, de la Peña LS, Kaplan FS, Shore EM. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 21: 902-9. PMID 16753021 DOI: 10.1359/Jbmr.060215 |
0.795 |
|
| 2006 |
Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nature Genetics. 38: 525-7. PMID 16642017 DOI: 10.1038/Ng1783 |
0.378 |
|
| 2005 |
Schaffer AA, Kaplan FS, Tracy MR, O'Brien ML, Dormans JP, Shore EM, Harland RM, Kusumi K. Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine. 30: 1379-85. PMID 15959366 DOI: 10.1097/01.Brs.0000166619.22832.2C |
0.427 |
|
| 2005 |
de la Peña LS, Billings PC, Fiori JL, Ahn J, Kaplan FS, Shore EM. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 1168-76. PMID 15940369 DOI: 10.1359/Jbmr.050305 |
0.797 |
|
| 2005 |
Shore EM, Kaplan FS. Fibrodysplasia Ossificans Progressiva and Progressive Osseous Heteroplasia: Two Genetic Disorders of Heterotopic Ossification Clinical Reviews in Bone and Mineral Metabolism. 3: 257-260. DOI: 10.1385/Bmm:3:3-4:257 |
0.486 |
|
| 2005 |
Billings PC, Wu Y, Caron R, de la Peña LS, Young B, Pacifici M, Glaser DL, Shore EM, Kaplan FS. Early Fibrodysplasia Ossificans Progressiva-Like Lesion Formation in Nude Mice Following Implantation of Lymphoblastoid Cells From FOP Patients Clinical Reviews in Bone and Mineral Metabolism. 3: 225-228. DOI: 10.1385/Bmm:3:3-4:225 |
0.347 |
|
| 2005 |
Kaplan FS, Fiori JL, de la Peña LS, Ahn J, Billings PC, Shore EM. Dysregulation of BMP4 Receptor Trafficking and Signaling in Fibrodysplasia Ossificans Progressiva Clinical Reviews in Bone and Mineral Metabolism. 3: 217-224. DOI: 10.1385/Bmm:3:3-4:217 |
0.802 |
|
| 2005 |
Kaplan FS, Hume D, Westermark A, Shore EM. The Craniofacial Phenotype of Fibrodysplasia Ossificans Progressiva Clinical Reviews in Bone and Mineral Metabolism. 3: 209-212. DOI: 10.1385/Bmm:3:3-4:209 |
0.401 |
|
| 2005 |
Shore EM, Feldman GJ, Xu M, Kaplan FS. The genetics of fibrodysplasia ossificans progressiva Clinical Reviews in Bone and Mineral Metabolism. 3: 201-204. DOI: 10.1385/Bmm:3:3-4:201 |
0.34 |
|
| 2005 |
Kaplan FS, Shore EM, Gupta R, Billings PC, Glaser DL, Pignolo RJ, Graf D, Kamoun M. Immunological features of fibrodysplasia ossificans progressiva and the dysregulated BMP4 pathway Clinical Reviews in Bone and Mineral Metabolism. 3: 189-193. DOI: 10.1385/Bmm:3:3-4:189 |
0.447 |
|
| 2005 |
Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P, Morhart R, Smith R, Le Merrer M, Rogers JG, Connor JM, Kitterman JA. The Phenotype of Fibrodysplasia Ossificans Progressiva Clinical Reviews in Bone and Mineral Metabolism. 3: 183-188. DOI: 10.1385/Bmm:3:3-4:183 |
0.475 |
|
| 2004 |
Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. The Journal of the American Academy of Orthopaedic Surgeons. 12: 116-25. PMID 15089085 |
0.421 |
|
| 2004 |
Kaplan FS, Glaser DL, Shore EM, Emerson SG. Letters to the Editor: Bone Marrow Tranplantation in a Patient with Fibrodysplasia Clinical Orthopaedics and Related Research. 422: 278-279. DOI: 10.1097/01.Blo.0000130715.46000.A3 |
0.405 |
|
| 2003 |
Glaser DL, Economides AN, Wang L, Liu X, Kimble RD, Fandl JP, Wilson JM, Stahl N, Kaplan FS, Shore EM. In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. The Journal of Bone and Joint Surgery. American Volume. 85: 2332-42. PMID 14668502 DOI: 10.2106/00004623-200312000-00010 |
0.509 |
|
| 2003 |
Hegyi L, Gannon FH, Glaser DL, Shore EM, Kaplan FS, Shanahan CM. Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification? The Journal of Pathology. 201: 141-8. PMID 12950027 DOI: 10.1002/Path.1413 |
0.445 |
|
| 2003 |
Ahn J, Serrano de la Pena L, Shore EM, Kaplan FS. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. The Journal of Bone and Joint Surgery. American Volume. 85: 667-74. PMID 12672843 DOI: 10.2106/00004623-200304000-00013 |
0.538 |
|
| 2003 |
Olmsted EA, Kaplan FS, Shore EM. Bone morphogenetic protein-4 regulation in fibrodysplasia ossificans progressiva. Clinical Orthopaedics and Related Research. 331-43. PMID 12616078 DOI: 10.1097/00003086-200303000-00044 |
0.439 |
|
| 2003 |
Faust RA, Shore EM, Stevens CE, Xu M, Shah S, Phillips CD, Kaplan FS. Progressive osseous heteroplasia in the face of a child. American Journal of Medical Genetics. Part A. 118: 71-5. PMID 12605446 DOI: 10.1002/Ajmg.A.10170 |
0.382 |
|
| 2003 |
Ahn J, Feldman G, Terry L, Shore EM, Kaplan FS. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva. Clinical Orthopaedics and Related Research. 205-13. PMID 12579020 DOI: 10.1097/01.Blo.0000030075.92399.11 |
0.447 |
|
| 2002 |
Shore EM, Ahn J, Jan de Beur S, Li M, Xu M, Gardner RJ, Zasloff MA, Whyte MP, Levine MA, Kaplan FS. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. The New England Journal of Medicine. 346: 99-106. PMID 11784876 DOI: 10.1056/Nejmoa011262 |
0.419 |
|
| 2001 |
Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS. Mast cell involvement in fibrodysplasia ossificans progressiva. Human Pathology. 32: 842-8. PMID 11521229 DOI: 10.1053/Hupa.2001.26464 |
0.371 |
|
| 2001 |
Mahboubi S, Glaser DL, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva. Pediatric Radiology. 31: 307-14. PMID 11379597 DOI: 10.1007/S002470100447 |
0.41 |
|
| 2001 |
Kaplan FS, Shore EM. Progressive osseous heteroplasia. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 15: 2084-94. PMID 11092391 DOI: 10.1359/Jbmr.2000.15.11.2084 |
0.434 |
|
| 2001 |
Eddy MC, Jan De Beur SM, Yandow SM, McAlister WH, Shore EM, Kaplan FS, Whyte MP, Levine MA. Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 15: 2074-83. PMID 11092390 DOI: 10.1359/Jbmr.2000.15.11.2074 |
0.409 |
|
| 2000 |
Yeh GL, Mathur S, Wivel A, Li M, Gannon FH, Ulied A, Audi L, Olmsted EA, Kaplan FS, Shore EM. GNAS1 mutation and Cbfa1 misexpression in a child with severe congenital platelike osteoma cutis Journal of Bone and Mineral Research. 15: 2063-2073. PMID 11092389 DOI: 10.1359/Jbmr.2000.15.11.2063 |
0.416 |
|
| 2000 |
Xu MQ, Feldman G, Le Merrer M, Shugart YY, Glaser DL, Urtizberea JA, Fardeau M, Connor JM, Triffitt J, Smith R, Shore EM, Kaplan FS. Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP). Clinical Genetics. 58: 291-8. PMID 11076054 DOI: 10.1034/J.1399-0004.2000.580407.X |
0.402 |
|
| 2000 |
Shore EM, Glaser DL, Gannon FH. Osteogenic induction in hereditary disorders of heterotopic ossification. Clinical Orthopaedics and Related Research. 303-16. PMID 10818990 DOI: 10.1097/00003086-200005000-00028 |
0.444 |
|
| 2000 |
Feldman G, Li M, Martin S, Urbanek M, Urtizberea JA, Fardeau M, LeMerrer M, Connor JM, Triffitt J, Smith R, Muenke M, Kaplan FS, Shore EM. Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. American Journal of Human Genetics. 66: 128-35. PMID 10631143 DOI: 10.1086/302724 |
0.395 |
|
| 1999 |
Virdi AS, Shore EM, Oreffo ROC, Li M, Connor JM, Smith R, Kaplan FS, Triffitt JT. Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva Calcified Tissue International. 65: 250-255. PMID 10441661 DOI: 10.1007/S002239900693 |
0.367 |
|
| 1998 |
Shore EM, Xu M, Shah PB, Janoff HB, Hahn GV, Deardorff MA, Sovinsky L, Spinner NB, Zasloff MA, Wozney JM, Kaplan FS. The human bone morphogenetic protein 4 (BMP-4) gene: molecular structure and transcriptional regulation. Calcified Tissue International. 63: 221-9. PMID 9701626 DOI: 10.1007/S002239900518 |
0.383 |
|
| 1998 |
Kaplan FS, Shore EM. Encrypted morphogens of skeletogenesis: biological errors and pharmacologic potentials. Biochemical Pharmacology. 55: 373-82. PMID 9514070 DOI: 10.1016/S0006-2952(97)00559-5 |
0.492 |
|
| 1998 |
Olmsted EA, Gannon FH, Wang Z, Grigoriadis AE, Wagner EF, Zasloff MA, Shore EM, Kaplan FS. Embryonic Overexpression of the c-Fos Protooncogene Clinical Orthopaedics and Related Research. 346: 81???94. DOI: 10.1097/00003086-199801000-00013 |
0.44 |
|
| 1998 |
Calvert GT, Shore EM. Human Leukocyte Antigen B27 Allele is not Correlated With Fibrodysplasia Ossificans Progressiva Clinical Orthopaedics and Related Research. 346: 66???70. DOI: 10.1097/00003086-199801000-00011 |
0.307 |
|
| 1998 |
Xu M, Shore EM. Mutational Screening of the Bone Morphogenetic Protein 4 Gene in a Family With Fibrodysplasia Ossificans Progressiva Clinical Orthopaedics and Related Research. 346: 53???58. DOI: 10.1097/00003086-199801000-00009 |
0.448 |
|
| 1998 |
Lanchoney TF, Olmsted EA, Shore EM, Gannon FA, Rosen V, Zasloff MA, Kaplan FS. Characterization of Bone Morphogenetic Protein 4 Receptor in Fibrodysplasia Ossificans Progressiva Clinical Orthopaedics and Related Research. 346: 38???45. DOI: 10.1097/00003086-199801000-00007 |
0.473 |
|
| 1997 |
Moriatis JM, Gannon FH, Shore EM, Bilker W, Zasloff MA, Kaplan FS. Limb swelling in patients who have fibrodysplasia ossificans progressiva. Clinical Orthopaedics and Related Research. 247-53. PMID 9060511 DOI: 10.1097/00003086-199703000-00033 |
0.304 |
|
| 1997 |
Gannon FH, Kaplan FS, Olmsted E, Finkel GC, Zasloff MA, Shore E. Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva Human Pathology. 28: 339-343. PMID 9042799 DOI: 10.1016/S0046-8177(97)90133-7 |
0.36 |
|
| 1997 |
Shore EM, Kaplan FS. Fibrodysplasia Ossificans Progressiva (FOP): The Value of Studying a Rare Disorder Drug Information Journal. 31: 273-277. DOI: 10.1177/009286159703100139 |
0.456 |
|
| 1996 |
Janoff HB, Muenke M, Johnson LO, Rosenberg A, Shore EM, Okereke E, Zasloff M, Kaplan FS. Fibrodysplasia ossificans progressiva in two half-sisters: evidence for maternal mosaicism. American Journal of Medical Genetics. 61: 320-4. PMID 8834042 DOI: 10.1002/(Sici)1096-8628(19960202)61:4<320::Aid-Ajmg4>3.0.Co;2-Y |
0.32 |
|
| 1996 |
Kaplan FS, Shore EM. Bone morphogenetic proteins and C-FOS: early signals in endochondral bone formation. Bone. 19: 13S-21S. PMID 8830995 DOI: 10.1016/S8756-3282(96)00129-9 |
0.5 |
|
| 1996 |
Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. The New England Journal of Medicine. 335: 555-61. PMID 8678932 DOI: 10.1056/Nejm199608223350804 |
0.477 |
|
| 1992 |
Hahn GV, Cohen RB, Wozney JM, Levitz CL, Shore EM, Zasloff MA, Kaplan FS. A bone morphogenetic protein subfamily: chromosomal localization of human genes for BMP5, BMP6, and BMP7. Genomics. 14: 759-62. PMID 1427904 DOI: 10.1016/S0888-7543(05)80181-8 |
0.381 |
|
| Show low-probability matches. |